Skip to main content
SGHT logo

Sight Sciences, Inc.

SGHTNASDAQHealthcareMedical Devices

$8.99Today:- (-)1Y +74.47%

As of Oct 23, 2026 close

Market cap
$490.01M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.38$9.71
Volume (live)
-
Avg. volume (3M)
313.32K

Sight Sciences (SGHT) Income Statement

Sight Sciences reported revenue of $77.36M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 3.1% from $79.87M a year earlier. Sight Sciences posted a net loss of $38.43M, compared with a net loss of $51.51M a year earlier. Gross margin was 86.2% and operating margin -48.0%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $23.39M, up 19.5% from the same quarter a year earlier.

Sight Sciences Income Statement Analysis

Values in millions USD

Scroll to see more
Sight Sciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue77.3679.8781.0671.3348.9627.6423.357.53
Cost of Revenue10.7011.5811.8812.368.619.216.542.34
Gross Profit66.6768.2969.1858.9740.3518.4316.805.19
Operating Expenses
Research & Development14.6117.9917.5622.8615.638.878.125.43
Selling, General & Administrative89.16100.83108.89120.0776.1941.7532.7214.06
Operating Expenses103.77118.82126.45142.9291.8250.6240.8419.49
Operating Income-37.10-50.53-57.27-83.95-51.48-32.19-24.04-14.30
Other Income/Expense
Interest Income3.975.927.290.000.000.030.170.00
Interest Expense5.144.66-5.41-4.474.372.401.960.00
Other Income/Expense-1.323.921.84-2.24-11.29-2.44-1.820.00
Income
Income Before Tax-38.42-51.27-55.44-86.20-62.77-34.63-25.86-14.30
Income Tax Expense0.010.240.110.050.190.060.01-0.01
Net Income-38.43-51.51-55.55-86.24-62.96-34.69-25.87-14.29
Net Income - Continuous Operations-38.43-51.51-55.55-86.24-62.96-34.69-25.87-14.29
Net Income - Discontinued Operations--------
EBITDA-32.79-45.90-56.66-83.24-57.21-31.68-23.47-14.23
EBIT-34.30-46.61-57.27-83.95-58.41-32.19--
Depreciation & Amortization0.490.710.610.711.200.550.430.06
Earnings Per Share
Basic EPS-1.00-1.00-1.00-2.00-1.00-1.00-1.00-
Diluted EPS-1.00-1.00-1.00-2.00-1.00-1.00-1.00-
Basic Shares Outstanding52.1550.1348.6347.8547.5046.7733.6332.20
Diluted Shares Outstanding52.1550.1348.6347.8547.5046.7733.6332.20

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Sight Sciences Financial Statements

What was Sight Sciences's revenue in fiscal 2025?

Sight Sciences reported revenue of $77.36M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 3.1% from $79.87M a year earlier.

Is Sight Sciences profitable?

No. Sight Sciences reported a net loss of $38.43M in fiscal 2025. In fiscal 2024 it lost $51.51M.

What is Sight Sciences's operating margin?

Sight Sciences's operating income was −$37.10M on revenue of $77.36M in fiscal 2025, an operating margin of -48.0%, compared with -63.3% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition